Abstract:Background: Perfluorohexane sulfonate (PFHxS) is a frequently detected per- and polyfluoroalkyl substance in most populations, including in individuals who are pregnant, a period critical for early life development. Despite epidemiological evidence of exposure, developmental toxicity, particularly at realistic human exposures, remains understudied. Objectives: We evaluated the effect of gestational exposure to human-relevant body burden of PFHxS on fetal and placental development and explored mechanisms of action combining alternative splicing (AS) and gene expression (GE) analyses. Methods: Pregnant ICR mice were exposed to 0, 0.03, and 0.3 mu g / kg / day from gestational day 7 to day 17 via oral gavage. Upon euthanasia, PFHxS distribution was measured using liquid chromatography-tandem mass spectrometry. Maternal and fetal phenotypes were recorded, and histopathology was examined for placenta impairment. Multiomics was adopted by combining AS and GE analyses to unveil disruptions in mRNA quality and quantity. The key metabolite transporters were validated by quantitative real-time PCR (qRT-PCR) for quantification and three-dimensional (3D) structural simulation by AlphaFold2. Targeted metabolomics based on liquid chromatography-tandem mass spectrometry was used to detect amino acid and amides levels in the placenta. Results: Pups developmentally exposed to PFHxS exhibited signs of intrauterine growth restriction (IUGR), characterized by smaller fetal weight and body length (p < 0.01 ) compared to control mice. PFHxS concentration in maternal plasma was 5.01 +/- 0.54 ng / mL . PFHxS trans-placenta distribution suggested dose-dependent transfer through placental barrier. Histopathology of placenta of exposed dams showed placental dysplasia, manifested with an attenuated labyrinthine layer area and deescalated blood sinus counts and placental vascular development index marker CD34. Combined GE and AS analyses pinpointed differences in genes associated with key biological processes of placental development, proliferation, metabolism, and transport in placenta of exposed dams compared to that of control dams. Further detection of placental key transporter gene expression, protein structure simulation, and amino acid and amide metabolites levels suggested that PFHxS exposure during pregnancy led to impairment of placental amino acid transportation. Discussion: The findings from this study suggest that exposure to human-relevant very-low-dose PFHxS during pregnancy in mice caused IUGR, likely via downregulating of placental amino acid transporters, thereby impairing placental amino acid transportation, resulting in impairment of placental development. Our findings confirm epidemiological findings and call for future attention on the health risk of this persistent yet ubiquitous chemical in the early developmental stage and provide a new approach for understanding gene expression from both quantitative and qualitative omics approaches in toxicological studies.

A Metabolomic Study on the Gender-Dependent Effects of Maternal Exposure to Fenvalerate on Neurodevelopment in Offspring Mice

Neurobehavior and Learning and Memory of Mice after Postnatal Exposure to Fenvalerate

Paternal fenvalerate exposure transgenerationally impairs cognition and hippocampus in female offspring

Effects of Fenvalerate on Enzymes in Testis of Male Offspring Rats after Maternal Exposure in Gestation

Excess Folic Acid Supplementation before and during Pregnancy and Lactation Alters Behaviors and Brain Gene Expression in Female Mouse Offspring

Significant metabolic alterations in mouse dams exposed to an environmental mixture of polychlorinated biphenyls (PCBs) during gestation and lactation: Insights into PCB and metabolite profiles

Evaluating the Effect of Gestational Exposure to Perfluorohexane Sulfonate on Placental Development in Mice Combining Alternative Splicing and Gene Expression Analyses

Transcriptomics integrated with metabolomics reveals perfluorobutane sulfonate (PFBS) exposure effect during pregnancy and lactation on lipid metabolism in rat offspring

Transcriptomic and Metabolomic Profile Changes in the Liver of Sprague Dawley Rat Offspring after Maternal PFOS Exposure During Gestation and Lactation

The Effect of Gestational PFOS Exposure on Metabolism in the F344 Rat

Effects of Intrauterine Fenvalerate Exposure on the Male Characteristics of Offspring Rats

Metabolomics Study and Meta-Analysis on the Association Between Maternal Pesticide Exposome and Birth Outcomes.

Metabolomics Analysis Explores the Rescue to Neurobehavioral Disorder Induced by Maternal PM2.5 Exposure in Mice.

Developmental toxicity and metabolomics analyses of zebrafish (Danio rerio) embryos exposed to Fenoxaprop-p-ethyl

Maternal transfer of F-53B inhibited neurobehavior in zebrafish offspring larvae and potential mechanisms: Dopaminergic dysfunction, eye development defects and disrupted calcium homeostasis

Prenatal Dexamethasone Exposure-Induced a Gender-Difference and Sustainable Multi-Organ Damage in Offspring Rats Via Serum Metabolic Profile Analysis.

Physiological and behavioral responses in offspring mice following maternal exposure to sulfamonomethoxine during pregnancy

Mechanisms Underlying Melatonin-Mediated Prevention of Fenvalerate-Induced Behavioral and Oxidative Toxicity in Zebrafish.

Exposure to fenvalerate causes brain impairment during zebrafish development.

Imbalance of Gut Microbiota and Fecal Metabolites in Offspring Female Mice Induced by Nitenpyram Exposure During Pregnancy

Effects of Prenatal Exposure to Perfluorononanoic Acid on Neurobehavioral Development in Rat Offspring